New TB Vaccines, an Experimental Nasal Shot, and Phase-3 Results: The Race to Replace BCG
On April 10, 2026, the British Medical Journal published results from the PreVenTB trial — a randomised, Phase-3 clinical trial conducted in India. The final stage of human testing before a vaccine can be considered for regulatory approval
By News4Bharat | 2026-04-11T08:34:05.519425+00:00
On April 10, 2026, the British Medical Journal published results from the PreVenTB trial — a randomised, Phase-3 clinical trial conducted in India. The final stage of human testing before a vaccine can be considered for regulatory approval
Source URL: https://news4bharat.com/health/new-tb-vaccines-an-experimental-nasal-shot-and-phase-3--20260411-tlwy/